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Summary
 
Itk, a Tec family tyrosine kinase, plays an important but as yet undefined role in T cell receptor
(TCR) signaling. Here we show that T cells from Itk-deficient mice have a TCR-proximal
signaling defect, resulting in defective interleukin 2 secretion. Upon TCR stimulation, Itk
 
2
 
/
 
2
 
T cells release normal amounts of calcium from intracellular stores, but fail to open plasma
membrane calcium channels. Since thapsigargin-induced store depletion triggers normal cal-
cium entry in Itk
 
2
 
/
 
2
 
 T cells, an impaired biochemical link between store depletion and chan-
nel opening is unlikely to be responsible for this defect. Biochemical studies indicate that
TCR-induced inositol 1,4,5 tris-phosphate (IP3) generation and phospholipase C 
 
g
 
1 tyrosine
phosphorylation are substantially reduced in Itk
 
2
 
/
 
2
 
 T cells. In contrast, TCR-
 
z
 
 and ZAP-70
are phosphorylated normally, suggesting that Itk functions downstream of, or in parallel to,
ZAP-70 to facilitate TCR-induced IP3 production. These findings support a model in which
quantitative differences in cytosolic IP3 trigger distinct responses, and in which only high con-
centrations of IP3 trigger the influx of extracellular calcium.
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T cell receptor signaling
 
T
 
cell activation is a complex process involving a num-
ber of independent signaling pathways. Of these, the
best understood is the signaling downstream of the TCR
(for review see reference 1). Biochemical as well as genetic
studies have identified many of the important signaling
molecules activated by TCR stimulation. For instance, the
tyrosine kinases ZAP-70 and Lck are known to play a criti-
cal role during T cell activation. Evidence also supports a
role for the Ras/Map kinase cascade, as well as the phos-
pholipid modifying enzyme, phosphatidyl inositol–3 kinase
(PI3K). To date, the precise role of each of these signaling
branches, as well as the mechanism(s) that integrate these
diverse signals, has not been completely elucidated. How-
ever, it has long been known that pharmacological agents
such as phorbol esters plus calcium ionophores can bypass
T cell surface receptors and directly activate resting T cells
(2). This phenomenon clearly pinpoints the critical role of
protein kinase C and calcium signaling in T cell activation.
The Tec family tyrosine kinases have been implicated in
antigen receptor signaling in a variety of hematopoietic cell
types. Itk, expressed in T cells and natural killer cells (3, 4),
is tyrosine phosphorylated in response to cross-linking of
the TCR (5, 6), CD28 (7), or CD2 (8). A closely related
family member, Btk, is expressed in B cells and mast cells;
immunodeficiency diseases in humans (XLA; references 9–11)
and mice (
 
xid
 
; references 12, 13) result from mutations in
the Btk gene, and are characterized by defects in B cell re-
ceptor (BCR) signaling (14–17). Furthermore, in Btk-defi-
cient chicken DT40 B cells, the antigen receptor–induced
tyrosine phosphorylation of the phospholipase C (PLC)
 
1
 
isoform PLC-
 
g
 
2 is substantially reduced, resulting in the
loss both of BCR-coupled phosphatidylinositol hydrolysis
and of calcium mobilization (18). Our studies suggested
that Itk might play an analogous role in TCR signaling in
T cells.
To test this possibility, we generated a line of Itk-defi-
cient mice. Previous studies have shown that Itk is impor-
tant for normal T cell development in the thymus and for
 
1
 
Abbreviations used in this paper:
 
 ES, embryonic stem; PI3, inositol 1,4,5
tris-phosphate; PLC, phospholipase C.
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normal T cell activation (19). However, the precise role of
Itk in TCR signal transduction has not yet been described.
Our studies have extended these previous observations by
demonstrating biochemical defects in Itk
 
2
 
/
 
2
 
 T cells. We
show that IL-2 secretion is dramatically reduced after TCR
stimulation of Itk
 
2
 
/
 
2
 
 T cells, and that this defect results, at
least in part, from impaired calcium signaling. We also
show that the failure to generate a sustained calcium flux in
Itk
 
2
 
/
 
2
 
 T cells is correlated with a dramatic reduction in
TCR-induced inositol 1,4,5 tris-phosphate (IP3) genera-
tion and with reduced tyrosine phosphorylation of PLC-
 
g
 
1. In contrast, TCR-induced tyrosine phosphorylation of
ZAP-70 and the TCR-
 
z
 
 chain are unaffected. These data
indicate that Itk is downstream of or parallel to ZAP-70,
and, furthermore, that Itk is an important component of the
signaling pathway leading to the sustained elevation of cy-
toplasmic free calcium necessary for the activation of tran-
scription factors such as c-rel and the nuclear factor of acti-
vated T cells (NFAT).
 
Materials and Methods
 
Generation of Itk-deficient Mice.
 
A murine strain 129 genomic
clone encoding the Itk kinase domain (exons 9, 10, 11, 12, and
13 [see Fig. 1]) was isolated. A 2.6-kb HindIII fragment extend-
ing from the middle of exon 10 to beyond exon 12 was replaced
by the 1.8-kb pGK-neo cassette; these deleted sequences encode
a portion of the Itk kinase domain (amino acids 476–543). The
targeting vector also contained 4.8 kb and 4.2 kb of flanking se-
quences at the 5
 
9
 
 and 3
 
9
 
 ends, respectively, and a 2.0-kb thymi-
dine kinase cassette (pGK-tk). The construct was linearized and
transfected into J1 (gift of Dr. A. Sharpe, Harvard Medical
School, Boston, MA) and CCE (gift of Dr. E. Robertson, Har-
vard University, Cambridge, MA) embryonic stem (ES) cell lines.
360 clones resistant to Geneticin (Sigma Chemical Co., St. Louis,
MO) and FIAU [1-(2
 
9
 
-deoxy-2
 
9
 
-fluro-
 
b
 
-
 
d
 
 arabinofuranosyl)-
5-iodouracil; gift of Dr. A. McMahon, Harvard University, Cam-
bridge, MA] were screened, yielding two homologous integrants,
one from each ES cell line. The ES clones were injected into
C57Bl/6 blastocysts to generate chimeric mice. Chimeras (male)
were backcrossed to C57Bl/6 females and progeny were screened
for the mutated Itk allele. Heterozygous Itk
 
1
 
/
 
2
 
 mice were inter-
crossed to generate Itk
 
2
 
/
 
2
 
 mice. Identical phenotypes were ob-
served for Itk
 
2
 
/
 
2
 
 mice generated from both of the two original
ES cell lines; these lines were used interchangeably. Mice were
maintained under specific pathogen-free conditions.
 
Cell Purification.
 
For CD4
 
1
 
 T cell purification, lymph node
(inguinal, axillary, brachial, mandibular, and mesenteric) cells
from multiple wild-type or Itk-deficient mice were isolated and
were purified on columns (Biotex Laboratories, Alberta, Canada)
according to the manufacturer’s protocol. The resulting cells
were 90–97% pure (Itk
 
1
 
/
 
1
 
 or Itk
 
1
 
/
 
2
 
) or 80–90% pure (Itk
 
2
 
/
 
2
 
)
CD4
 
1
 
 T cells.
 
Antibodies and Flow Cytometry Analysis.
 
Before antibody stain-
ing 10
 
6
 
 lymph node cells were plated in wells precoated with 5 
 
m
 
g/
ml goat anti–hamster IgG(H
 
1
 
L) followed by 5 
 
m
 
g/ml hamster
anti-mouse CD3
 
e
 
 (PharMingen, San Diego, CA). After 18–20 h
of stimulation, cells were stained with the following antibodies: bioti-
nylated anti-CD3
 
e
 
 (PharMingen, San Diego, CA), biotinylated
anti-CD69 (PharMingen), biotinylated anti-CD25 (PharMingen),
biotinylated anti-CD62L (PharMingen), FITC-conjugated anti–
TCR-
 
a
 
/
 
b
 
 (PharMingen), PE-conjugated anti-CD4 (GIBCO BRL,
Bethesda, MD), and CD8-Red (GIBCO BRL); secondary re-
agent was streptavidin-FITC (Southern Biotechnology Associates,
Birmingham, AL). Cells were analyzed on a FACScan
 
Ò
 
 using the
CellQuest software (Becton Dickinson, Mountain View, CA). Im-
munoprecipitations and Western blotting were done with antibod-
ies to the following proteins: Itk (monoclonal antibodies 7F10 and
10B2; reference 6), Tec (gift of Dr. B. Tang, St. Jude Children’s
Research Hospital, Memphis, TN), TCR-
 
z
 
 (Santa Cruz Biotech,
Santa Cruz, CA), ZAP-70 (Santa Cruz Biotech), and PLC-
 
g
 
1
(Santa Cruz Biotech and Upstate Biotechnology, Lake Placid,
NY). Anti-phosphotyrosine antibody 4G10 was a gift from Dr.
B. Druker (Oregon Health Sciences Center, Portland, OR).
 
TCR Stimulation and IL-2 Assays.
 
For T cell stimulations, 5
 
3 
 
10
 
4
 
 purified CD4
 
1
 
 T cells were plated in wells precoated with
goat anti–hamster antibody (5 
 
m
 
g/ml) followed by hamster anti–
mouse CD3
 
e
 
 (0.5 
 
m
 
g/ml). Where indicated, a 1:8 dilution (de-
termined to be saturating by cell surface staining) of anti-CD28
antibody supernatant (37N.D1; a gift from Dr. J. Allison (Univer-
sity of California at Berkeley, Berkeley, CA; reference 20) was
added. As a control, cells were also stimulated with PMA (1 ng/
ml) plus ionomycin (500 ng/ml). After 24 h of stimulation, the
supernatants were assessed for IL-2 concentration using HT-2 in-
dicator cells as previously described (21).
 
Calcium Flux.
 
5 
 
3 
 
10
 
6
 
/ml purified CD4
 
1
 
 cells were incu-
bated with 3 
 
m
 
g/ml fluo-3, 5 
 
m
 
g/ml Fura-Red, 0.5% pluronic
acid (Molecular Probes, Eugene, OR), and 2% FCS in RPMI for
30–50 min. Dye-loaded cells were washed twice with RPMI and
left at room temperature for 30 min in the dark before use. 1.5 
 
3
 
10
 
6
 
 (in 300 
 
m
 
l) dye-loaded cells were placed in 1 ml of serum-free
RPMI and warmed to 37
 
8
 
C. Stimulated cells were analyzed on a
FACScan
 
Ò
 
. The mean fluorescence ratio (FL-1:FL-3) was calcu-
lated using the FACSAssistant
 
Ò
 
 program.
 
Immunoprecipitation and Western Blotting.
 
Purified CD4
 
1
 
 T
cells were incubated in serum-free RPMI for 2 h at 37
 
8
 
C before
stimulation. Cells were then washed twice, resuspended in 120 
 
m
 
l
of RPMI containing 25 
 
m
 
g/ml biotinylated anti-CD3
 
e
 
 antibody,
and incubated on ice for 10 min. 50 
 
m
 
g/ml of streptavidin (Sigma
Chemical Co.) was then added, and cells were incubated at 37
 
8
 
C
for the indicated times; signaling was terminated by diluting the
samples into 1 ml of ice-cold PBS containing 20 mM NaF and
1 mM Na
 
3
 
VO
 
4
 
. Cells were then lysed in lysis buffer (0.5% Brij97,
20 mM Tris, pH 8, 100 mM NaCl, 1 mM EDTA, 20 mM NaF,
and 1 mM Na
 
3
 
VO
 
4
 
) supplemented with protease inhibitors. Im-
munoprecipitations were done with lysate from 3 
 
3 
 
10
 
6
 
 cells.
Immunoprecipitated proteins were resolved by 8 or 12% SDS-
PAGE, transferred to Immobilon-P membranes (Millipore, Bed-
ford, MA), and blocked and probed as previously described (22).
 
Analysis of IP3 Release.
 
8 
 
3 
 
10
 
6
 
 purified CD4
 
1
 
 T cells were
starved in serum-free RPMI for 1 h at 37
 
8
 
C before stimulation.
Cells were stimulated as for immunoprecipitation studies, but at
3.2 
 
3 
 
10
 
7
 
/ml; signaling was terminated by adding 50 
 
m
 
l ice-cold
100% Trichloroacetic acid. IP3 levels were assessed using the IP3
Radioreceptor Assay Kit (NEN Life Science Products, Boston,
MA) following the manufacturer’s protocol. Controls included
medium alone or mock-stimulated (no primary antibody) cells.
 
Results and Discussion
 
To determine the function of Itk in T cell signaling, we
generated Itk-deficient mice by gene targeting. Exons of
the Itk gene encoding critical regions of the kinase domain 
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were deleted, and replaced with the neo
 
R
 
 cassette (Fig. 1 
 
a
 
).
Mice homozygous for the mutated Itk allele (Itk
 
2
 
/
 
2
 
; see
Fig. 1 
 
b
 
) fail to express any Itk protein in lymph nodes,
spleen, or thymus (Fig. 1 
 
c
 
). Consistent with a previous re-
port on Itk-deficient mice (19), T cell development is ab-
normal in the absence of the Itk protein. Specifically, the
size and general histology of the thymus are normal, but
CD4
 
1
 
 T cell maturation is diminished in Itk
 
2
 
/
 
2
 
 mice. The
number of CD4
 
1
 
 T cells in peripheral lymphoid organs is
reduced to 
 
z
 
50% of that found in wild-type mice; in con-
trast, the number of CD8
 
1
 
 T cells is unchanged (data not
shown).
To investigate the role of Itk in TCR signaling, we ex-
amined the responses of Itk
 
2
 
/
 
2
 
 CD4
 
1 T cells to TCR
stimulation. First, Itk2/2 lymph node cells were stimulated
with plate-bound anti-CD3 antibody, and cells were as-
sessed 18–20 h later for changes in surface marker expres-
sion. CD25 and CD69 were upregulated and CD62L (L-
selectin) was downregulated after TCR stimulation on
both mutant and wild-type cells (Fig. 2 a). The only differ-
ence we consistently observed was a somewhat higher de-
gree of CD25 upregulation on Itk1/1 cells compared with
Itk2/2 cells; this difference is most likely due to the IL-2–
induced increase in IL-2 receptor a chain (CD25) expres-
sion, which is lacking in Itk2/2 T cells (see below). These
data indicate that the TCR-dependent signaling pathways
leading to changes in activation marker and adhesion mole-
cule expression are intact in Itk2/2 T cells. Second, we ex-
amined IL-2 secretion in response to TCR stimulation.
When purified CD41 Itk2/2 T cells were stimulated with
anti-CD3 antibody, no IL-2 could be detected in the su-
pernatants after overnight culture (Fig. 2 b). Stimulation
with anti-CD3 plus anti-CD28 antibodies, which dramati-
cally enhances IL-2 production from wild-type cells, re-
sulted in detectable, but still reduced, IL-2 secretion from
Itk2/2 T cells. This signaling defect is proximal to the
TCR, as stimulation with PMA plus ionomycin, which
bypasses the early stages of TCR signaling, elicits compara-
ble IL-2 secretion by Itk2/2 and wild-type T cells.
The functional defect in IL-2 production after stimula-
tion of Itk2/2 T cells suggested a defect in the TCR signal-
ing pathway leading to IL-2 transcription. Since IL-2 pro-
moter activity is highly dependent on TCR-induced
Figure 1. Disruption of the Itk gene. (a) Domain structure of the Itk
protein and physical map of the Itk genomic clone. Relative positions of
exons 9–13 are depicted in checkered boxes. S, Sac I; H, HindIII; TH,
Tec homology domain; PH, pleckstrin homology domain; PRO, proline-
rich region; TK, thymidine kinase cassette; Neo, neomycinR cassette. The
probe used for Southern blot analysis is depicted by a hatched box. (b)
Southern blot of tail DNA from Itk1/1 (1/1), Itk1/2 (1/2), and Itk2/2
(2/2) mice. DNA was digested with SacI, which yields a 9.5-kb band
from the wild-type allele and a 7.5-kb band from the mutant allele. (c)
Total lysate of 5 3 106 cells from lymph node (LN), spleen (SP), or thy-
mus (TH) from the indicated mice were immunoblotted with anti-Itk
monoclonal antibody (top panel); filter was stripped and reprobed with
anti-Tec antibody (bottom panel).
Figure 2. Defective IL-2 production by Itk2/2 T cells. (a) Total lymph
node cells were analyzed for expression of CD25, CD69, and CD62L af-
ter 18–20 h of activation by plate-bound anti-CD3e antibody. Histogram
of live gated CD41 cells are shown. Open histograms show expression of
markers when cultured in media alone; filled histograms show expression
of markers after stimulation. (b) Purified CD41 T cells were stimulated
with plate-bound anti-CD3e antibody (p.b. CD3), anti-CD3e plus anti-
CD28 antibodies (CD31CD28), or PMA plus ionomycin (PMA1Iono),
and analyzed for IL-2 secretion after 24 h. Graph is representative of four
similar experiments.1724 Itk Is Required for TCR-induced Capacitative Calcium Entry
sustained increases in cytoplasmic free calcium (23–25), we
examined calcium responses after TCR stimulation of
CD41 T cells. In wild-type cells, TCR cross-linking elicits
the expected large, transient peak of increased calcium in
the cytoplasm, followed by a sustained elevation in intra-
cellular calcium (Fig. 3 a). In contrast, Itk2/2 T cells have a
substantially reduced initial peak of elevated cytoplasmic
calcium and do not sustain elevated calcium levels. This re-
sponse requires high concentrations of the stimulating anti-
CD3e antibody (10 mg/ml); when lower concentrations of
antibody are used, wild-type T cells display a slower and
more flattened elevation in intracellular calcium, whereas
Itk2/2 T cells fail to respond altogether (data not shown).
These differences are not due to defective dye loading in
the mutant cells, as ionomycin induces equivalent large in-
creases in cytoplasmic calcium in both cell types (Fig. 3 a).
Although the defective calcium influx observed with high
concentrations of stimulating antibody is novel, the more
severe defect observed with lower concentrations of stimu-
lating antibody parallels the defect observed upon surface
immunoglobulin cross-linking of Btk2/2 chicken B cells
(18). It is not clear if the partial defect observed at high
concentrations of stimulating antibody would also be ob-
served in the B cell system.
In normal cells, the overall pattern of calcium elevation
results from two components of the calcium response. The
initial transient peak is due to the release of calcium from
intracellular stores (26); the resulting depletion of these
stores triggers the opening of the plasma membrane cal-
cium channels, generating a sustained elevation in intracel-
lular calcium (27). To determine whether Itk2/2 T cells are
defective in one or both of these components of the cal-
cium response, we chelated the extracellular calcium with
EGTA, eliminating the influx of calcium and thereby re-
vealing the release of calcium from intracellular stores. In
the presence of EGTA, the transient calcium increase in-
duced by TCR cross-linking is similar in both wild-type
and mutant cells (Fig. 3 b), suggesting that the intracellular
calcium stores are released (and therefore depleted) to a
similar extent in both cell types. Nonetheless, when extra-
cellular Ca21 is restored, allowing the influx of calcium
across the plasma membrane, wild-type cells sustain a sub-
stantially higher level of intracellular calcium than do mu-
tant cells. These data indicate that the signaling pathways
opening plasma membrane calcium channels in response to
store depletion are defective in Itk2/2 T cells, resulting in
the reduced level of calcium elevation after TCR stimula-
tion. Since sustained calcium elevation is required for the
sustained nuclear translocation of nuclear factor of activated
T cells (NFAT) and for IL-2 transcription (23–25), the fail-
ure of Itk2/2 cells to sustain intracellular calcium levels is
likely to be a direct cause of the reduced IL-2 production
observed after TCR stimulation.
To determine whether the depletion of intracellular cal-
cium stores is competent to induce the opening of plasma
membrane calcium channels, wild-type and mutant T cells
were treated with the drug thapsigargin. Thapsigargin, a
specific inhibitor of the Ca21-ATPase in the endoplasmic
reticulum membrane, prevents the uptake of cytosolic cal-
cium and results in a leak that depletes intracellular calcium
Figure 3. Defective calcium
flux response after TCR stimula-
tion of Itk2/2 T cells. Purified
CD41 T cells were stimulated
and monitored for 600 s after
gating on live cells. The intracel-
lular calcium concentration is
plotted as the FL1/FL3 ratio
over time. (a) Calcium response
after CD3 cross-linking. 500 ng/
ml ionomycin was added as a
control at 500 s to assess the effi-
ciency of dye loading. (b) Calcium
response after CD3 cross-linking
in the presence of extracellular
EGTA (0.5 mM) sufficient to
chelate the calcium present in
the RPMI media (z0.4 mM).
Extracellular calcium was added
back to a final concentration of
0.5 mM free Ca21 midway
through the experiment. (c) In-
tracellular calcium elevation in
response to 1 mM thapsigargin
(Tg). Extracellular EGTA was
added midway through the ex-
periment. (d) Thapsigargin (Tg)-
induced calcium elevation in the
presence of EGTA (0.5 mM).
Solid lines, control (Itk1/1 and
Itk1/2) cells; dashed lines, Itk2/2
cells. 
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stores and triggers calcium entry (28, 29). In contrast to
anti-CD3 antibody cross-linking, thapsigargin treatment
initiates a substantial calcium influx in both wild-type and
mutant T cells, demonstrating that store-operated calcium
entry is normal in Itk
 
2
 
/
 
2
 
 T cells (Fig. 3 
 
c
 
). It is possible that
distinct depletion-sensitive signaling pathways are induced
depending on the mechanism of store depletion; however,
we favor a model in which the channel-operating calcium
stores are depleted to a lesser extent in the Itk
 
2
 
/
 
2
 
 cells. This
latter hypothesis is consistent with the reduced production
of IP3 observed after TCR stimulation of Itk
 
2
 
/
 
2
 
 T cells
(see below).
In the presence of extracellular EGTA, thapsigargin in-
duces similar levels of calcium elevation in mutant and
wild-type T cell (Fig. 3 
 
d
 
), suggesting that the sizes of the
thapsigargin-sensitive intracellular calcium stores are similar
in both cell types. Notably, the thapsigargin-stimulated
calcium release observed in these naive T cells is unexpect-
edly small, yet capable of stimulating calcium influx. In
light of this result, it is surprising that the large calcium re-
lease observed upon TCR stimulation in Itk-deficient T
cells fails to trigger calcium influx. This apparent contradic-
tion could be explained in at least three ways. First, the ex-
tent of calcium elevation in the presence of thapsigargin
may be a poor measure of store depletion, as rates of store
refilling may differ between wild-type and Itk
 
2
 
/
 
2
 
 T cells.
Second the similar extent of store release observed between
wild-type and Itk
 
2
 
/
 
2
 
 cells may underestimate the actual
difference in total calcium released if the rate at which cal-
cium is cleared from the cyotosol increases as the concen-
tration of cytosolic calcium increases; this phenomenon has
been documented previously in T cells (30). Third, it is
possible that the thapsigargin-sensitive intracellular stores
are a distinct and small subset of the TCR-coupled intra-
cellular calcium stores, and are uniquely competent to trig-
ger calcium influx in response to depletion. In this latter
case, Itk would be required to couple the TCR to these
specific channel-operating calcium stores.
It should be noted that the amplitude of the thapsigar-
gin-induced calcium elevation is always slightly diminished
in Itk-deficient T cells (Fig. 3 
 
c
 
). When purified cell popu-
lations are gated to exclude contaminating CD4
 
2
 
 cells, the
same difference is observed (data not shown); therefore,
this difference is not due to disparities in the purities of the
CD4
 
1
 
 T cell preparations from mutant and wild-type
lymph nodes. The absence of Itk could affect peak intracel-
lular calcium levels by multiple mechanisms, potentially re-
ducing the frequency of calcium channel opening, decreas-
ing the electrochemical gradient driving calcium entry, or
by facilitating the upregulation of the plasma membrane
calcium pump. At present we do not know which, if any,
of these mechanisms result in the reduction in maximum
intracellular calcium levels induced by thapsigargin.
TCR-induced calcium responses in T cells are initiated
by the second messenger, IP3. IP3 is generated by the
PLC-mediated hydrolysis of the membrane phospholipid,
phosphatidylinositol 4,5-bisphosphate (PIP2). After PIP2
cleavage, IP3 diffuses through the cytoplasm and binds to
IP3 receptors, inducing the release of calcium from internal
stores (for review see reference 31). In addition, IP3 is
thought to play a role in the subsequent calcium signal that
causes the opening of the plasma membrane calcium chan-
nels (32). Therefore, we assessed the levels of IP3 generated
after TCR stimulation of wild-type and Itk
 
2
 
/
 
2
 
 T cells (Fig.
4 
 
a
 
). In wild-type cells, IP3 levels begin to rise by 45 s after
TCR stimulation, remain at peak levels between 1 and 2
min, and return to basal levels by 5 min (Fig. 4 
 
a 
 
and data
not shown). In contrast, no significant increase in IP3 levels
over background can be detected in Itk
 
2
 
/
 
2
 
 
 
T cells at any
time point (Fig. 4 and data not shown). Parekh et al. have
demonstrated that calcium release can be triggered by IP3
concentrations 50-fold below those required to trigger cal-
cium influx (32). The minimal calcium-releasing doses of
IP3 identified by Parekh are at the limit of detection of our
assay system, and it is likely that TCR stimulation in Itk
 
2
 
/
 
2
 
T cells actually induces small amounts of IP3 that activate
calcium release without triggering calcium influx. It is un-
clear why this threshold effect exists. As proposed by
Figure 4. Reduced PLC-g1
phosphorylation and IP3 pro-
duction by activated Itk2/2 T
cells. (a) Purified CD41 T cells
from wild-type (WT) and Itk2/2
(KO) mice were incubated in the
presence (1stimulation) or ab-
sence (mock) of anti-CD3e anti-
body for 1.5 min; cell lysates
were prepared and analyzed for
IP3 levels. A value obtained
from medium in the absence of
cells is shown (medium). Averages
and standard deviations were cal-
culated from two to three inde-
pendent experiments. (b) Puri-
fied CD41 T cells from wild-type (1/1) and Itk2/2 (2/2) mice were stimulated by anti-CD3e antibody cross-linking. PLC-g1, CD3z, and ZAP-70
were immunoprecipitated from the cell lysates and immunoblotted for phosphotyrosine (n 5 3). In the case of PLC-g1, the membrane was reprobed to
detect the immunoprecipitated protein.
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Parekh et al., it could result either from a low affinity IP3-
receptor present on a specialized channel-coupled calcium
store, or from the need for IP3 concentrations sufficient to
allow diffusion to outpace the catabolism of IP3 (32).
The PLC isoform PLC-g1 is abundant in T cells and ty-
rosine phosphorylated after TCR stimulation. Since this
PLC isoform is activated by tyrosine phosphorylation (33),
we examined whether reduced tyrosine phosphorylation of
PLC-g1 could account for the defective TCR-induced IP3
production in Itk2/2 T cells. As shown in Fig. 4 b, immu-
noblotting of PLC-g1 with an antiphosphotyrosine anti-
body indicated that the tyrosine phosphorylation of PLC-
g1 from stimulated Itk2/2 T cells is markedly reduced at
0.5 and 1 min. This reduced phosphorylation is not due to
decreased levels of PLC-g1, as demonstrated by anti-PLC-g1
immunoblotting (Fig. 4 b). In contrast, the TCR-induced
phosphorylation of the receptor-proximal signaling mole-
cules ZAP-70 and TCR-z is similar in both wild-type and
Itk2/2 T cells. Furthermore, the overall pattern of tyrosine
phosphorylation induced by TCR stimulation, with minor
exceptions, is not markedly different between Itk1/1 and
Itk2/2 T cells (data not shown); in addition, some down-
stream functions of TCR signaling are intact (e.g., changes
in activation marker expression, see above). Since ZAP-70
activation is critical for TCR signaling (34, 35), our data
suggest that ZAP-70 activation is normal in the absence of
Itk. These data indicate that Itk is not upstream of either
TCR-z or ZAP-70 phosphorylation, but is required for
optimal PLC-g1 activation after TCR cross-linking. This
placement of Itk relative to ZAP-70 is consistent with that
proposed by Kurosaki et al. for Btk and Syk (17).
Here we demonstrate that Itk2/2 T cells have a defect in
TCR signaling that leads to reduced IL-2 secretion after
TCR cross-linking. Although we have not ruled out addi-
tional signaling defects in Itk2/2 T cells, the impaired in-
flux of calcium across the plasma membrane is likely to be
responsible for the loss of TCR-induced IL-2 production.
Since calcium influx enables the sustained increases in cyto-
plasmic calcium required for transcription factor activation
(23–25), this defect could explain the inability of Itk2/2 T
cells to secrete IL-2. As calcium release from intracellular
stores appears normal in the Itk2/2 T cells, these data sug-
gest that Itk might be involved in the signaling pathways
coupling store depletion to calcium influx. However, we
found this explanation unlikely because thapsigargin in-
duces calcium influx in the absence of Itk. This finding
suggests that a functional depletion-sensing pathway can be
decoupled from calcium release. Defective coupling could
result from impaired PLC-g1 activation in Itk2/2 T cells
by at least two mechanisms. The dramatically reduced pro-
duction of IP3 after TCR stimulation in Itk2/2 T cells
could fail to trigger a low affinity IP3 receptor on a chan-
nel-operating subset of intracellular calcium stores, while
fully activating calcium release from the remaining stores.
Alternatively, the low levels of IP3 produced in the Itk2/2
T cells could fail to deplete intracellular calcium stores to
the extent required to trigger calcium influx. In this case,
we would be forced to conclude that the observed store re-
lease is a poor measure of actual store depletion, either be-
cause we are underestimating release in the wild-type T
cells, or because the rates at which the stores refill differ be-
tween the wild-type and Itk2/2 T cells. We believe that
this is the first demonstration that the TCR-induced influx
of extracellular calcium can be uncoupled from the TCR-
induced release of intracellular calcium, while preserving
functional, depletion-sensitive calcium influx mechanisms.
Thus, these experiments suggest that Itk2/2 T cells will pro-
vide an interesting model system for detailed studies of the
precise mechanisms regulating intracellular calcium levels.
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